We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.

UCLA Innovation Fund Biomedical Competition - LOI Due
Deadline: March 30, 2018 11:55 PM

This deadline has passed and is no longer active

In order to advance therapeutics, medical devices/diagnostics, and digital health technologies across campus, the UCLA Technology Development Group (TDG), UCLA Health / David Geffen School of Medicine (DGSOM), UCLA Henry Samueli School of Engineering & Applied Science (HSSEAS), School of Dentistry (SOD) and the College's Divisions of Life Sciences and Physical Sciences are collaborating to present the UCLA Innovation Fund. This opportunity is open to UCLA faculty from all Schools who have signed the UCLA Patent Policy.

The UCLA Innovation Fund’s goal is to more quickly move technologies from idea to the market, bridging the gap between academia and industry / investor interest.  Successful outcomes include, but are not limited to, a 1) license to an existing company; 2) license to a newly created company; 3) finding that a project no longer has technical or commercial potential.

Importantly, this is not a traditional research award.  Funding will be used to advance a project along to reach a key project-specific milestone, further enabling these technologies to be licensed to an existing company or a startup. These funds are to support commercialization activities that would not be supported by basic research grants.

There is a three-step application process, which requires a Letter of Intent, Full Application (by invitation only), and a Pitch Presentation (by invitation only).

Click here for more information. 

Return to Deadline Listings